Spiriva Respimat

February 20, 2017February 20, 2017

Asthmatic Kids 6 and Older Can Now Use Spiriva Respimat Spray as Maintenance Therapy

Asthma, News

The U.S. Food and Drug Administration (FDA) expanded the approval of steroid-free Spiriva Respimat (tiotropium bromide) for the maintenance treatment of asthma in children ages 6 and older. The FDA ... Read more

September 19, 2016September 19, 2016

Spiriva Respimat Safely Improves Lung Function in Kids with Asthma, New Study Results Show

Asthma, News

Boehringer Ingelheim recently announced new results showing that Spiriva Respimat (tiotropium bromide) improved lung function in asthmatic children ages 6 to 11. Data also suggested the drug is safe in children ages 6 ... Read more

March 8, 2016March 8, 2016

Allergic Asthma Patients Show Improvement by Adding Spiriva Respimat to Therapy, According to New Analyses of Data

Asthma, News

Boehringer Ingelheim Pharmaceuticals recently announced that adding its soft mist inhaler device Spiriva Respimat to deliver asthma maintenance drugs helps patients with allergic asthma better control their symptoms. The findings were presented at the ... Read more

February 5, 2016May 13, 2016

New Inhaled Asthma Treatment, SPIRIVA RESPIMAT, Now Available in U.S.

Asthma, COPD, News

Boehringer Ingelheim Pharmaceuticals recently announced that SPIRIVA RESPIMAT, a new inhaled medicine for maintenance treatment of asthma, is now available by prescription in U.S. pharmacies for adults and adolescents. The U.S. Food ... Read more

September 22, 2015November 6, 2015

Boehringer Ingelheim to Present New Data for COPD, IPF and Asthma at European Respiratory Society International Congress

Asthma, Idiopathic Pulmonary Fibrosis, News

Boehringer Ingelheim plans to roll out several major presentations focusing for its respiratory disease portfolio at the upcoming European Respiratory Society (ERS) International Congress, September 26-30. The German company is currently ... Read more

September 17, 2015November 6, 2015

FDA Approves SPIRIVA Respimat as Asthma Maintenance Therapy

Asthma, News

One of the world’s leading pharmaceutical companies, Boehringer Ingelheim, has just announced its inhalation spray for COPD, SPIRIVA Respimat (tiotropium bromide), has received approval from the US Food and Drug Administration ... Read more

January 23, 2015January 23, 2015

Spiriva Respimat by Boehringer for COPD Now Available Nationwide

News

Boehringer Ingelheim Pharmaceuticals, Inc. has just announced the nationwide retail availability of prescription SPIRIVA®RESPIMAT® (tiotropium bromide) Inhalation Spray, which was recently granted US Food and Drug Administration approval as a long-term, once-daily maintenance ... Read more

November 5, 2014November 6, 2015

FDA Agrees To Review Spiriva Respimat By Boehringer Ingelheim To Treat Asthma

Asthma, News

The Food and Drug Administration (FDA) recently agreed to review a new drug application (NDA) by Boehringer Ingelheim for Spiriva Respimat (tiotropium bromide) Inhalation Spray to treat asthma. Spiriva Respimat is an experimental therapy ... Read more